BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31672779)

  • 1. Non-inferiority trials in cardiology: what clinicians need to know.
    Leung JT; Barnes SL; Lo ST; Leung DY
    Heart; 2020 Jan; 106(2):99-104. PubMed ID: 31672779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal Use of the Non-Inferiority Trial Design.
    Angeli F; Verdecchia P; Vaudo G; Masnaghetti S; Reboldi G
    Pharmaceut Med; 2020 Jun; 34(3):159-165. PubMed ID: 32277352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-inferiority versus superiority drug claims: the (not so) subtle distinction.
    Ganju J; Rom D
    Trials; 2017 Jun; 18(1):278. PubMed ID: 28619049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of disinvestment from weekend allied health services across acute medical and surgical wards: 2 stepped-wedge cluster randomised controlled trials.
    Haines TP; Bowles KA; Mitchell D; O'Brien L; Markham D; Plumb S; May K; Philip K; Haas R; Sarkies MN; Ghaly M; Shackell M; Chiu T; McPhail S; McDermott F; Skinner EH
    PLoS Med; 2017 Oct; 14(10):e1002412. PubMed ID: 29088237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superiority and non-inferiority: two sides of the same coin?
    Dunn DT; Copas AJ; Brocklehurst P
    Trials; 2018 Sep; 19(1):499. PubMed ID: 30223881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-inferiority trials: determining whether alternative treatments are good enough.
    Scott IA
    Med J Aust; 2009 Mar; 190(6):326-30. PubMed ID: 19296815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current issues in clinical equivalence trials.
    Blackwelder WC
    J Dent Res; 2004; 83 Spec No C():C113-5. PubMed ID: 15286135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When inferiority meets non-inferiority: implications for interim analyses.
    Bratton DJ; Williams HC; Kahan BC; Phillips PP; Nunn AJ
    Clin Trials; 2012 Oct; 9(5):605-9. PubMed ID: 22796636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methodological aspects of superiority, equivalence, and non-inferiority trials.
    Stefanos R; Graziella D'; Giovanni T
    Intern Emerg Med; 2020 Sep; 15(6):1085-1091. PubMed ID: 32705494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-inferiority trials using a surrogate marker as the primary endpoint: An increasing phenotype in cardiovascular trials.
    Bikdeli B; Caraballo C; Welsh J; Ross JS; Kaul S; Stone GW; Krumholz HM
    Clin Trials; 2020 Dec; 17(6):723-728. PubMed ID: 32838556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of non-inferiority randomized trials using the difference in restricted mean survival times.
    Weir IR; Trinquart L
    Clin Trials; 2018 Oct; 15(5):499-508. PubMed ID: 30074407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-inferiority and equivalence trials: Key methodological issues].
    Herr M; Descatha A; Aegerter P
    Rev Med Interne; 2018 May; 39(5):352-359. PubMed ID: 28693836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interim monitoring for non-inferiority trials: minimizing patient exposure to inferior therapies.
    Korn EL; Freidlin B
    Ann Oncol; 2018 Mar; 29(3):573-577. PubMed ID: 29267937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation.
    Quartagno M; Walker AS; Babiker AG; Turner RM; Parmar MKB; Copas A; White IR
    Trials; 2020 Feb; 21(1):145. PubMed ID: 32029000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring how non-inferiority and equivalence are assessed in paediatrics: a systematic review.
    Aupiais C; Zohar S; Taverny G; Le Roux E; Boulkedid R; Alberti C
    Arch Dis Child; 2018 Nov; 103(11):1067-1075. PubMed ID: 29794107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and analysis of non-inferiority mortality trials in oncology.
    Rothmann M; Li N; Chen G; Chi GY; Temple R; Tsou HH
    Stat Med; 2003 Jan; 22(2):239-64. PubMed ID: 12520560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Methodological and statistical aspects of equivalence and non inferiority trials].
    Elie C; De Rycke Y; Jais JP; Marion-Gallois R; Landais P
    Rev Epidemiol Sante Publique; 2008 Aug; 56(4):267-77. PubMed ID: 18703296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing non-inferiority: a combination approach.
    Gao P; Ware JH
    Stat Med; 2008 Feb; 27(3):392-406. PubMed ID: 17575568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-inferiority tests for anti-infective drugs using control group quantiles.
    Fay MP; Follmann DA
    Clin Trials; 2016 Dec; 13(6):632-640. PubMed ID: 27430709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-inferiority trials: are they inferior? A systematic review of reporting in major medical journals.
    Rehal S; Morris TP; Fielding K; Carpenter JR; Phillips PP
    BMJ Open; 2016 Oct; 6(10):e012594. PubMed ID: 27855102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.